Calculate your body mass index (BMI)
Dates are flexible
● Multiple sclerosis
Up to: $3,000
Male, Female, Smoker, Non-Smoker
Paid research study for people with relapsing forms of multiple sclerosis (MS).
The purpose of this study is to assess the safety, tolerability, and metabolism of an investigational drug, administered 4 times over a 6 month period, in patients with relapsing forms of multiple sclerosis (relapsing-remitting MS or secondary progressive MS), ages 18 to 60.
Eligible patients may be taking beta-interferons, Copaxone, Aubagio, Gilenya, Tecfidera, or no MS medication.
Participation involves 2 screening visits, 4 doses of study drug ~every 28 days (with optional inpatient admission), and 8 outpatient visits.